Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
29.22
+0.22 (0.76%)
Jul 6, 2026, 4:00 PM EDT - Market closed
Bicara Therapeutics Market Cap
Bicara Therapeutics has a market cap or net worth of $1.92 billion as of July 6, 2026. Its market cap has increased by 273.31% in one year.
Market Cap
1.92B
Enterprise Value
1.38B
1-Year Change
273.31%
Ranking
Category
Stock Price
$29.22
Market Cap Chart
Since the IPO on September 13, 2024, Bicara Therapeutics's market cap has increased from $931.70M to $1.92B, an increase of 106.06%. That is a compound annual growth rate of 49.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 1.92B | 108.23% |
| Dec 31, 2025 | 921.98M | -2.74% |
| Dec 31, 2024 | 947.92M | 1.74% |
| Sep 13, 2024 | 931.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Absci | 1.97B |
| Syndax Pharmaceuticals | 1.93B |
| Iovance Biotherapeutics | 1.92B |
| Zymeworks | 1.92B |
| AtaiBeckley | 1.91B |
| Rapport Therapeutics | 1.86B |
| GH Research | 1.85B |
| UroGen Pharma | 1.85B |